Bär & Karrer advised Alpine Select, an investment company listed on the SIX Swiss Exchange with domicile in Zug, as its shareholders approved the introduction of a statutory opting up provision at the ordinary
Tags :Dieter Dubs
Euronext Paris-listed outdoor advertising company JCDecaux signed a share purchase agreement with NZZ, under which JCDecaux will sell 325,519 APG|SGA’s shares, corresponding to 10.85% of the share capital of APG|SGA. In connection with the
Bär & Karrer advised private equity investor Advent as ZI Zenith S.à r.l., a European indirect subsidiary of funds managed and/or advised by Advent International itself, completed the public tender offer for
Homburger advised Aktiengesellschaft für die Neue Zürcher Zeitung (NZZ) on the acquisition of a 25%-stake in APG SGA (APG|SGA) from the two anchor shareholders JCDecaux, advised by Bär & Karrer, and
ELANTAS, a subsidiary of the specialty German chemicals group ALTANA, entered into a share purchase agreement with the von Finck family and tender agreements with the von Roll management pursuant to which ELANTAS will acquire
The American company Lupa Investment Holdings and the Basel based MCH Group have entered into a commitment agreement in which Lupa committed to purchase a certain number of new shares in connection with a rights
FEMSA and Valora join forces in an agreement for the acquisition of Valora Holding by FEMSA. The leading Latin American retailer will acquire Swiss Valora in a cash tender offer. Fomento Económico Mexicano, S.
On 27 January 2022, Liechtensteinische Landesbank (LLB), 74.9%-majority shareholder of Bank Linth LLB, has published the pre-announcement for a public tender offer to acquire all of the outstanding shares of Bank Linth. LLB will offer Bank Linth
Liechtensteinische Landesbank (LLB) intends to increase the shareholding in its subsidiary Bank Linth LLB (Bank Linth) to 100%. For this purpose, LLB has published on 27 January 2022 the pre-announcement for a public takeover offer to acquire the
CSL Limited, a global biotechnology company based in Australia and Vifor Pharma, a Swiss-based global pharmaceutical company, entered into an agreement for CSL to launch an all-cash public tender offer to acquire all publicly held
